Xin Liao

Xin Liao

Auto-generated profile, based on publicly available information

Xin Liao

Department of Epidemiology and Health Statistics, XiangYa School of Public Health, Central South University, Changsha, China; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LHLiu Huang
Liu Huang
TZTao Zhang
Tao Zhang
CXConghua Xie
Conghua Xie
XLXin Liao
Xin Liao
QYQianqian Yu
Qianqian Yu
XYXianglin Yuan
Xianglin Yuan
Rapid response to chemotherapy in metastatic colorectal cancer (mCRC) patients (response within 12 weeks of chemotherapy) may increase the chance of complete resection and improved survival. Few molecular markers predict irinotecan-induced rapid response and survival. Single-nucleotide polymorphisms (SNPs) in solute carrier genes are reported to correlate with the variable pharmacokinetics of irinotecan and folate in cancer patients. This study aims to evaluate the predictive role of 3 SNPs in mCRC patients treated with irinotecan and fluoropyrimidine-containing regimens. Three SNPs were selected and genotyped in 137 mCRC patients from a Chinese prospective multicenter trial (NCT01282658). The chi-squared test, univariate and multivariable logistic regression model, and receiver operating characteristic analysis were used to evaluate correlations between the genotypes and rapid response. Kaplan-Meier survival analysis and Cox proportional hazard models were used to evaluate the associations between genotypes and survival outcomes. Benjamini and Hochberg False Discovery Rate correction was used in multiple testing Genotype GA/AA of SNP rs2306283 of the gene SLCO1B1 and genotype GG of SNP rs1051266 of the gene SLC19A1 were associated with a higher rapid response rate (odds ratio [OR] =3.583 and 3.521, 95%CI =1.301-9.871 and 1.271-9.804, p=0.011 and p=0.013, respectively). The response rate was 70% in patients with both genotypes, compared with only 19.7% in the remaining patients (OR = 9.489, 95%CI = 2.191-41.093, Fisher's exact test p=0.002). Their significances were all maintained even after multiple testing (all pc < 0.05). The rs2306283 GA/AA genotype was also an independent prognostic factor of longer progression-free survival (PFS) (hazard ratio = 0.402, 95%CI = 0.171-0.945, p=0.037). None of the SNPs predicted overall survival. Polymorphisms of solute carriers’ may be useful to predict rapid response to irinotecan plus fluoropyrimidine and PFS in mCRC patients. ClinicalTrials.gov NCT01282658 http://www.clinicaltrials.gov/ct2/show/NCT01282658

29 March 2019 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
XLXin Liao
Xin Liao
TZTong Zhang
Tong Zhang
BLBingyang Li
Bingyang Li
SHShimin Hu
Shimin Hu
JLJunyu Liu
Junyu Liu
Junxia YanJunxia Yan
Junxia Yan
RNF213 rare variant-p.R4810K (rs112735431) was significantly associated with intracranial artery stenosis/occlusion disease (ICASO) in Japan and Korea and to a lesser degree in China. Considering the allelic heterogeneity, we performed target exome sequencing of RNF213 with the aim to identify the rare variants spectrum and their association with ICASO in a Chinese population and further to explore whether the rare variants carrier patients present specific clinical phenotype. Target exome sequencing of RNF213 was performed in 250 ICASO patients using FastTarget sequencing technology. Various filtering process were used to select the candidate variants. Control individuals were obtain from 1000 Genome Project (208 Chinese samples) and GeneSky in-house database (1007 samples). Gene-based association analyses were conducted to identify the association between RNF213 rare variants and ICASO. The clinical characteristics of rare variant carriers and non-carriers were compared using Chi-squared test or Fisher’s exact test. After filtration, 18 rare variants were identified in 39 patients. Gene-based association test showed that rare variants of RNF213 were significantly associated with ICASO (Minor allele frequency < 0.05, WSS p = 4.88 × 10− 10; SKAT p = 9.68 × 10− 6; SKAT-O p = 3.42 × 10− 9). There were no significant clinical characteristic differences other than the diagnosis age which was older in the carriers than the non-carriers (60.5 ± 6.2 vs 57.3 ± 8.9 years old, p = 0.028). Rare variants of RNF213 are associated with ICASO in Chinese. However, there are limited genetic diagnosis values of the gene due to no specific phenotypic presentation in the carriers and non carrier patients.

1 January 2019 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
BLBingyang Li
Bingyang Li
CHChongyu Hu
Chongyu Hu
JLJunyu Liu
Junyu Liu
XLXin Liao
Xin Liao
JXJiayu Xun
Jiayu Xun
Junxia YanJunxia Yan
Junxia Yan
Li B, et al. Yonsei Med J. 2019 Jul;60(7):651-658. https://doi.org/10.3349/ymj.2019.60.7.651

1 January 2020 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
LHLiming Hu
Liming Hu
BLBingyang Li
Bingyang Li
XLXin Liao
Xin Liao
Junxia YanJunxia Yan
Junxia Yan
Hu L, et al. Yonsei Med J. 2020 May;61(5):391-399. https://doi.org/10.3349/ymj.2020.61.5.391

1 April 2021 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
JLJunyu Liu
Junyu Liu
CHChongyu Hu
Chongyu Hu
YLYifeng Li
Yifeng Li
BLBingyang Li
Bingyang Li
XLXin Liao
Xin Liao
Junxia YanJunxia Yan
Junxia Yan

16 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LXLu Xu
Lu Xu
LHLiming Hu
Liming Hu
CHChongyu Hu
Chongyu Hu
JLJunyu Liu
Junyu Liu
BLBingyang Li
Bingyang Li
Junxia YanJunxia Yan
Junxia Yan
Intracranial aneurysm (IA) is a complex disease caused by genetic and environmental factors. Evidence indicates that inflammation plays an important role in IA occurrence. We aimed to explore the associations between inflammatory cytokine gene polymorphisms and IA in a Chinese population. This study enrolled 768 participants of Han ethnicity, including 384 patients with IA and 384 healthy individuals. Sixteen single nucleotide polymorphisms (SNPs) of IL1, IL6, IL12, and TNF-α genes were genotyped using the Sequenom MassARRAY platform. Univariate and multivariate logistic regression analyses were used to analyze the associations. We found IL12B rs3181216 was significantly associated with IA in the recessive and additive models (OR = 0.46, 95% CI = 0.23–0.89, P = 0.022; OR = 0.74, 95% CI = 0.56–0.98, P = 0.034, respectively). TNF-α rs1799964 was associated with IA in dominant and additive models (OR = 0.67, 95% CI = 0.46–0.98, P = 0.041; OR = 0.71, 95% CI = 0.51–0.98, P = 0.034, respectively). IL1A rs17561 was associated with single IA susceptibility (dominant model: OR = 0.52, 95% CI = 0.31–0.85, P = 0.040). The IL12B rs3181216 polymorphism was associated with single IA susceptibility in the recessive model (OR = 0.41, 95% CI = 0.18–0.93, P = 0.033). The IL12B rs2195940 polymorphism was associated with multiple IAs susceptibility (dominant model: OR = 0.28, 95% CI = 0.09–0.89, P = 0.031; additive model: OR = 0.28, 95% CI = 0.09–0.90, P = 0.032). TNF-α rs1799964 was associated with multiple IAs susceptibility in the dominant model (OR = 0.54, 95% CI = 0.30–0.97, P = 0.040). No associations were found between other polymorphisms and IA susceptibility. Therefore, IL1A, IL12B, and TNF-α gene polymorphisms are associated with IA susceptibility in a Chinese population.